nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupivacaine—CYP2D6—Lomustine—brain cancer	0.146	0.218	CbGbCtD
Bupivacaine—CYP1A2—Carmustine—brain cancer	0.144	0.216	CbGbCtD
Bupivacaine—CYP2D6—Hydroxyurea—brain cancer	0.111	0.166	CbGbCtD
Bupivacaine—CYP3A4—Temozolomide—brain cancer	0.109	0.163	CbGbCtD
Bupivacaine—CYP3A4—Lomustine—brain cancer	0.0928	0.139	CbGbCtD
Bupivacaine—CYP1A2—Etoposide—brain cancer	0.0428	0.0641	CbGbCtD
Bupivacaine—CYP3A4—Etoposide—brain cancer	0.0224	0.0336	CbGbCtD
Bupivacaine—PTGER1—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00655	0.117	CbGpPWpGaD
Bupivacaine—PTGER1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.00454	0.0811	CbGpPWpGaD
Bupivacaine—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00262	0.0468	CbGpPWpGaD
Bupivacaine—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00239	0.0426	CbGpPWpGaD
Bupivacaine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00204	0.0365	CbGpPWpGaD
Bupivacaine—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00203	0.0363	CbGpPWpGaD
Bupivacaine—Lidocaine—EGFR—brain cancer	0.00197	0.523	CrCbGaD
Bupivacaine—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.00187	0.0334	CbGpPWpGaD
Bupivacaine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00186	0.0332	CbGpPWpGaD
Bupivacaine—Lidocaine—CYP2C9—brain cancer	0.0018	0.477	CrCbGaD
Bupivacaine—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.00126	0.0225	CbGpPWpGaD
Bupivacaine—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.00121	0.0216	CbGpPWpGaD
Bupivacaine—SCN10A—ganglion—brain cancer	0.00121	0.149	CbGeAlD
Bupivacaine—Urinary incontinence—Temozolomide—brain cancer	0.00117	0.00444	CcSEcCtD
Bupivacaine—Numbness—Etoposide—brain cancer	0.00117	0.00444	CcSEcCtD
Bupivacaine—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.00116	0.0207	CbGpPWpGaD
Bupivacaine—Apnoea—Etoposide—brain cancer	0.00115	0.00434	CcSEcCtD
Bupivacaine—Neuropathy—Temozolomide—brain cancer	0.00114	0.00432	CcSEcCtD
Bupivacaine—Drowsiness—Procarbazine—brain cancer	0.00112	0.00426	CcSEcCtD
Bupivacaine—Sensory loss—Etoposide—brain cancer	0.00112	0.00425	CcSEcCtD
Bupivacaine—Infection—Lomustine—brain cancer	0.00112	0.00425	CcSEcCtD
Bupivacaine—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00111	0.0199	CbGpPWpGaD
Bupivacaine—Extravasation—Etoposide—brain cancer	0.00111	0.00422	CcSEcCtD
Bupivacaine—Cardiovascular disorder—Etoposide—brain cancer	0.00111	0.00419	CcSEcCtD
Bupivacaine—Pain—Carboplatin—brain cancer	0.0011	0.00418	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Procarbazine—brain cancer	0.0011	0.00417	CcSEcCtD
Bupivacaine—Sweating—Procarbazine—brain cancer	0.00108	0.00408	CcSEcCtD
Bupivacaine—Skin discolouration—Etoposide—brain cancer	0.00108	0.00408	CcSEcCtD
Bupivacaine—Haematuria—Procarbazine—brain cancer	0.00107	0.00406	CcSEcCtD
Bupivacaine—Blood creatinine increased—Hydroxyurea—brain cancer	0.00106	0.00401	CcSEcCtD
Bupivacaine—Body temperature increased—Carboplatin—brain cancer	0.00102	0.00386	CcSEcCtD
Bupivacaine—Injury—Carmustine—brain cancer	0.000992	0.00376	CcSEcCtD
Bupivacaine—Vascular purpura—Temozolomide—brain cancer	0.000985	0.00373	CcSEcCtD
Bupivacaine—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000981	0.0175	CbGpPWpGaD
Bupivacaine—Decreased appetite—Lomustine—brain cancer	0.000981	0.00372	CcSEcCtD
Bupivacaine—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000944	0.0169	CbGpPWpGaD
Bupivacaine—Flushing—Procarbazine—brain cancer	0.000936	0.00355	CcSEcCtD
Bupivacaine—Purpura—Temozolomide—brain cancer	0.000914	0.00347	CcSEcCtD
Bupivacaine—Neuropathy—Etoposide—brain cancer	0.000912	0.00346	CcSEcCtD
Bupivacaine—Diplopia—Carmustine—brain cancer	0.000912	0.00346	CcSEcCtD
Bupivacaine—Chills—Procarbazine—brain cancer	0.000905	0.00343	CcSEcCtD
Bupivacaine—Arrhythmia—Procarbazine—brain cancer	0.000901	0.00341	CcSEcCtD
Bupivacaine—Body temperature increased—Lomustine—brain cancer	0.000892	0.00338	CcSEcCtD
Bupivacaine—Diplopia—Temozolomide—brain cancer	0.000881	0.00334	CcSEcCtD
Bupivacaine—Drowsiness—Hydroxyurea—brain cancer	0.000869	0.00329	CcSEcCtD
Bupivacaine—Infestation NOS—Hydroxyurea—brain cancer	0.000869	0.00329	CcSEcCtD
Bupivacaine—Infestation—Hydroxyurea—brain cancer	0.000869	0.00329	CcSEcCtD
Bupivacaine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000865	0.0154	CbGpPWpGaD
Bupivacaine—Tension—Procarbazine—brain cancer	0.000861	0.00326	CcSEcCtD
Bupivacaine—Nervousness—Procarbazine—brain cancer	0.000852	0.00323	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000852	0.00323	CcSEcCtD
Bupivacaine—Tremor—Procarbazine—brain cancer	0.000822	0.00312	CcSEcCtD
Bupivacaine—Anaemia—Procarbazine—brain cancer	0.000811	0.00307	CcSEcCtD
Bupivacaine—Muscular weakness—Carmustine—brain cancer	0.000804	0.00305	CcSEcCtD
Bupivacaine—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.000793	0.00301	CcSEcCtD
Bupivacaine—Dysphagia—Carmustine—brain cancer	0.000788	0.00299	CcSEcCtD
Bupivacaine—Syncope—Procarbazine—brain cancer	0.000787	0.00298	CcSEcCtD
Bupivacaine—Muscular weakness—Temozolomide—brain cancer	0.000777	0.00295	CcSEcCtD
Bupivacaine—Alanine aminotransferase increased—Temozolomide—brain cancer	0.000777	0.00295	CcSEcCtD
Bupivacaine—Loss of consciousness—Procarbazine—brain cancer	0.000771	0.00292	CcSEcCtD
Bupivacaine—Abdominal distension—Temozolomide—brain cancer	0.000767	0.00291	CcSEcCtD
Bupivacaine—Cough—Procarbazine—brain cancer	0.000766	0.0029	CcSEcCtD
Bupivacaine—Dysphagia—Temozolomide—brain cancer	0.000761	0.00289	CcSEcCtD
Bupivacaine—Convulsion—Procarbazine—brain cancer	0.00076	0.00288	CcSEcCtD
Bupivacaine—Hypertension—Procarbazine—brain cancer	0.000758	0.00287	CcSEcCtD
Bupivacaine—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000757	0.0135	CbGpPWpGaD
Bupivacaine—Arthralgia—Procarbazine—brain cancer	0.000747	0.00283	CcSEcCtD
Bupivacaine—Anxiety—Procarbazine—brain cancer	0.000745	0.00282	CcSEcCtD
Bupivacaine—Sweating increased—Temozolomide—brain cancer	0.000742	0.00281	CcSEcCtD
Bupivacaine—Anaphylactoid reaction—Etoposide—brain cancer	0.000728	0.00276	CcSEcCtD
Bupivacaine—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000728	0.013	CbGpPWpGaD
Bupivacaine—Confusional state—Procarbazine—brain cancer	0.000722	0.00274	CcSEcCtD
Bupivacaine—Vomiting—Lomustine—brain cancer	0.000717	0.00272	CcSEcCtD
Bupivacaine—Oedema—Procarbazine—brain cancer	0.000716	0.00271	CcSEcCtD
Bupivacaine—Infection—Procarbazine—brain cancer	0.000712	0.0027	CcSEcCtD
Bupivacaine—Shock—Procarbazine—brain cancer	0.000705	0.00267	CcSEcCtD
Bupivacaine—Chills—Hydroxyurea—brain cancer	0.0007	0.00265	CcSEcCtD
Bupivacaine—Tachycardia—Procarbazine—brain cancer	0.000699	0.00265	CcSEcCtD
Bupivacaine—Hyperhidrosis—Procarbazine—brain cancer	0.000692	0.00262	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Carmustine—brain cancer	0.000689	0.00261	CcSEcCtD
Bupivacaine—Urinary tract infection—Carmustine—brain cancer	0.000683	0.00259	CcSEcCtD
Bupivacaine—Erythema—Hydroxyurea—brain cancer	0.000679	0.00257	CcSEcCtD
Bupivacaine—Infestation NOS—Temozolomide—brain cancer	0.000679	0.00257	CcSEcCtD
Bupivacaine—Infestation—Temozolomide—brain cancer	0.000679	0.00257	CcSEcCtD
Bupivacaine—Cardiac arrest—Etoposide—brain cancer	0.00067	0.00254	CcSEcCtD
Bupivacaine—Nausea—Lomustine—brain cancer	0.00067	0.00254	CcSEcCtD
Bupivacaine—Hypotension—Procarbazine—brain cancer	0.000669	0.00254	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Temozolomide—brain cancer	0.000666	0.00252	CcSEcCtD
Bupivacaine—Urinary tract infection—Temozolomide—brain cancer	0.00066	0.0025	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000653	0.00247	CcSEcCtD
Bupivacaine—Insomnia—Procarbazine—brain cancer	0.000648	0.00246	CcSEcCtD
Bupivacaine—Paraesthesia—Procarbazine—brain cancer	0.000643	0.00244	CcSEcCtD
Bupivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000642	0.0115	CbGpPWpGaD
Bupivacaine—Somnolence—Procarbazine—brain cancer	0.000637	0.00241	CcSEcCtD
Bupivacaine—Anaemia—Hydroxyurea—brain cancer	0.000628	0.00238	CcSEcCtD
Bupivacaine—Hypoaesthesia—Carmustine—brain cancer	0.000628	0.00238	CcSEcCtD
Bupivacaine—Decreased appetite—Procarbazine—brain cancer	0.000623	0.00236	CcSEcCtD
Bupivacaine—Alanine aminotransferase increased—Etoposide—brain cancer	0.000622	0.00236	CcSEcCtD
Bupivacaine—Oedema peripheral—Carmustine—brain cancer	0.000621	0.00236	CcSEcCtD
Bupivacaine—Constipation—Procarbazine—brain cancer	0.000612	0.00232	CcSEcCtD
Bupivacaine—Pain—Procarbazine—brain cancer	0.000612	0.00232	CcSEcCtD
Bupivacaine—Dysphagia—Etoposide—brain cancer	0.000609	0.00231	CcSEcCtD
Bupivacaine—Hypoaesthesia—Temozolomide—brain cancer	0.000606	0.0023	CcSEcCtD
Bupivacaine—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000605	0.0108	CbGpPWpGaD
Bupivacaine—PTGER1—endocrine gland—brain cancer	0.000605	0.0744	CbGeAlD
Bupivacaine—Oedema peripheral—Temozolomide—brain cancer	0.0006	0.00228	CcSEcCtD
Bupivacaine—Bronchospasm—Etoposide—brain cancer	0.000599	0.00227	CcSEcCtD
Bupivacaine—PTGER1—head—brain cancer	0.000597	0.0734	CbGeAlD
Bupivacaine—Sweating increased—Etoposide—brain cancer	0.000594	0.00225	CcSEcCtD
Bupivacaine—Feeling abnormal—Procarbazine—brain cancer	0.00059	0.00224	CcSEcCtD
Bupivacaine—Convulsion—Hydroxyurea—brain cancer	0.000588	0.00223	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Procarbazine—brain cancer	0.000586	0.00222	CcSEcCtD
Bupivacaine—Flushing—Carmustine—brain cancer	0.000585	0.00222	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000574	0.00218	CcSEcCtD
Bupivacaine—Urticaria—Procarbazine—brain cancer	0.000569	0.00216	CcSEcCtD
Bupivacaine—Tinnitus—Temozolomide—brain cancer	0.000568	0.00215	CcSEcCtD
Bupivacaine—Abdominal pain—Procarbazine—brain cancer	0.000566	0.00215	CcSEcCtD
Bupivacaine—Body temperature increased—Procarbazine—brain cancer	0.000566	0.00215	CcSEcCtD
Bupivacaine—Flushing—Temozolomide—brain cancer	0.000566	0.00214	CcSEcCtD
Bupivacaine—Cardiac disorder—Temozolomide—brain cancer	0.000566	0.00214	CcSEcCtD
Bupivacaine—Arrhythmia—Carmustine—brain cancer	0.000563	0.00214	CcSEcCtD
Bupivacaine—Oedema—Hydroxyurea—brain cancer	0.000554	0.0021	CcSEcCtD
Bupivacaine—Mental disorder—Carmustine—brain cancer	0.000553	0.00209	CcSEcCtD
Bupivacaine—Infection—Hydroxyurea—brain cancer	0.000551	0.00209	CcSEcCtD
Bupivacaine—Erythema—Carmustine—brain cancer	0.000549	0.00208	CcSEcCtD
Bupivacaine—Malnutrition—Carmustine—brain cancer	0.000549	0.00208	CcSEcCtD
Bupivacaine—Chills—Temozolomide—brain cancer	0.000547	0.00207	CcSEcCtD
Bupivacaine—PTGER1—central nervous system—brain cancer	0.000545	0.067	CbGeAlD
Bupivacaine—Nervous system disorder—Hydroxyurea—brain cancer	0.000544	0.00206	CcSEcCtD
Bupivacaine—Infestation NOS—Etoposide—brain cancer	0.000543	0.00206	CcSEcCtD
Bupivacaine—Infestation—Etoposide—brain cancer	0.000543	0.00206	CcSEcCtD
Bupivacaine—Skin disorder—Hydroxyurea—brain cancer	0.000538	0.00204	CcSEcCtD
Bupivacaine—Mental disorder—Temozolomide—brain cancer	0.000534	0.00202	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Etoposide—brain cancer	0.000533	0.00202	CcSEcCtD
Bupivacaine—Back pain—Carmustine—brain cancer	0.000531	0.00201	CcSEcCtD
Bupivacaine—Erythema—Temozolomide—brain cancer	0.000531	0.00201	CcSEcCtD
Bupivacaine—Malnutrition—Temozolomide—brain cancer	0.000531	0.00201	CcSEcCtD
Bupivacaine—Hypersensitivity—Procarbazine—brain cancer	0.000528	0.002	CcSEcCtD
Bupivacaine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000523	0.00934	CbGpPWpGaD
Bupivacaine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00052	0.00929	CbGpPWpGaD
Bupivacaine—Vision blurred—Carmustine—brain cancer	0.000517	0.00196	CcSEcCtD
Bupivacaine—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000516	0.00922	CbGpPWpGaD
Bupivacaine—Tremor—Carmustine—brain cancer	0.000514	0.00195	CcSEcCtD
Bupivacaine—Asthenia—Procarbazine—brain cancer	0.000514	0.00195	CcSEcCtD
Bupivacaine—Back pain—Temozolomide—brain cancer	0.000513	0.00195	CcSEcCtD
Bupivacaine—Anaemia—Carmustine—brain cancer	0.000507	0.00192	CcSEcCtD
Bupivacaine—Pruritus—Procarbazine—brain cancer	0.000507	0.00192	CcSEcCtD
Bupivacaine—Agitation—Carmustine—brain cancer	0.000505	0.00191	CcSEcCtD
Bupivacaine—Vision blurred—Temozolomide—brain cancer	0.0005	0.0019	CcSEcCtD
Bupivacaine—Tremor—Temozolomide—brain cancer	0.000497	0.00188	CcSEcCtD
Bupivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000495	0.00885	CbGpPWpGaD
Bupivacaine—Dyspnoea—Hydroxyurea—brain cancer	0.000494	0.00187	CcSEcCtD
Bupivacaine—Somnolence—Hydroxyurea—brain cancer	0.000493	0.00187	CcSEcCtD
Bupivacaine—PTGER1—GPCR ligand binding—PTCH2—brain cancer	0.000492	0.00879	CbGpPWpGaD
Bupivacaine—Anaemia—Temozolomide—brain cancer	0.00049	0.00186	CcSEcCtD
Bupivacaine—Diarrhoea—Procarbazine—brain cancer	0.00049	0.00186	CcSEcCtD
Bupivacaine—Dyspepsia—Hydroxyurea—brain cancer	0.000488	0.00185	CcSEcCtD
Bupivacaine—Agitation—Temozolomide—brain cancer	0.000488	0.00185	CcSEcCtD
Bupivacaine—Hypoaesthesia—Etoposide—brain cancer	0.000485	0.00184	CcSEcCtD
Bupivacaine—Angioedema—Temozolomide—brain cancer	0.000485	0.00184	CcSEcCtD
Bupivacaine—PTGER1—G alpha (q) signalling events—TRPC6—brain cancer	0.000485	0.00866	CbGpPWpGaD
Bupivacaine—Decreased appetite—Hydroxyurea—brain cancer	0.000482	0.00183	CcSEcCtD
Bupivacaine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000481	0.00859	CbGpPWpGaD
Bupivacaine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000479	0.00181	CcSEcCtD
Bupivacaine—Convulsion—Carmustine—brain cancer	0.000476	0.0018	CcSEcCtD
Bupivacaine—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000475	0.00848	CbGpPWpGaD
Bupivacaine—Hypertension—Carmustine—brain cancer	0.000474	0.0018	CcSEcCtD
Bupivacaine—Pain—Hydroxyurea—brain cancer	0.000474	0.0018	CcSEcCtD
Bupivacaine—Constipation—Hydroxyurea—brain cancer	0.000474	0.0018	CcSEcCtD
Bupivacaine—Dizziness—Procarbazine—brain cancer	0.000474	0.0018	CcSEcCtD
Bupivacaine—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000471	0.00842	CbGpPWpGaD
Bupivacaine—Palpitations—Temozolomide—brain cancer	0.000469	0.00178	CcSEcCtD
Bupivacaine—SCN10A—telencephalon—brain cancer	0.000466	0.0573	CbGeAlD
Bupivacaine—Anxiety—Carmustine—brain cancer	0.000466	0.00177	CcSEcCtD
Bupivacaine—Cough—Temozolomide—brain cancer	0.000463	0.00176	CcSEcCtD
Bupivacaine—Convulsion—Temozolomide—brain cancer	0.00046	0.00174	CcSEcCtD
Bupivacaine—Hypertension—Temozolomide—brain cancer	0.000458	0.00174	CcSEcCtD
Bupivacaine—Feeling abnormal—Hydroxyurea—brain cancer	0.000457	0.00173	CcSEcCtD
Bupivacaine—Vomiting—Procarbazine—brain cancer	0.000455	0.00173	CcSEcCtD
Bupivacaine—Flushing—Etoposide—brain cancer	0.000453	0.00172	CcSEcCtD
Bupivacaine—Cardiac disorder—Etoposide—brain cancer	0.000453	0.00172	CcSEcCtD
Bupivacaine—Confusional state—Carmustine—brain cancer	0.000452	0.00171	CcSEcCtD
Bupivacaine—Arthralgia—Temozolomide—brain cancer	0.000452	0.00171	CcSEcCtD
Bupivacaine—Anxiety—Temozolomide—brain cancer	0.00045	0.00171	CcSEcCtD
Bupivacaine—Headache—Procarbazine—brain cancer	0.000449	0.0017	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000449	0.0017	CcSEcCtD
Bupivacaine—Oedema—Carmustine—brain cancer	0.000448	0.0017	CcSEcCtD
Bupivacaine—Infection—Carmustine—brain cancer	0.000445	0.00169	CcSEcCtD
Bupivacaine—SCN4A—pituitary gland—brain cancer	0.000445	0.0547	CbGeAlD
Bupivacaine—Body temperature increased—Hydroxyurea—brain cancer	0.000438	0.00166	CcSEcCtD
Bupivacaine—Chills—Etoposide—brain cancer	0.000438	0.00166	CcSEcCtD
Bupivacaine—Tachycardia—Carmustine—brain cancer	0.000437	0.00166	CcSEcCtD
Bupivacaine—Confusional state—Temozolomide—brain cancer	0.000437	0.00166	CcSEcCtD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000434	0.00775	CbGpPWpGaD
Bupivacaine—Anaphylactic shock—Temozolomide—brain cancer	0.000433	0.00164	CcSEcCtD
Bupivacaine—Oedema—Temozolomide—brain cancer	0.000433	0.00164	CcSEcCtD
Bupivacaine—PTGER1—GPCR downstream signaling—OR4C12—brain cancer	0.000432	0.00771	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—OR14C36—brain cancer	0.000432	0.00771	CbGpPWpGaD
Bupivacaine—Infection—Temozolomide—brain cancer	0.00043	0.00163	CcSEcCtD
Bupivacaine—Nausea—Procarbazine—brain cancer	0.000425	0.00161	CcSEcCtD
Bupivacaine—Nervous system disorder—Temozolomide—brain cancer	0.000425	0.00161	CcSEcCtD
Bupivacaine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000424	0.00757	CbGpPWpGaD
Bupivacaine—Skin disorder—Temozolomide—brain cancer	0.000421	0.00159	CcSEcCtD
Bupivacaine—Hypotension—Carmustine—brain cancer	0.000419	0.00159	CcSEcCtD
Bupivacaine—Hyperhidrosis—Temozolomide—brain cancer	0.000419	0.00159	CcSEcCtD
Bupivacaine—Back pain—Etoposide—brain cancer	0.000411	0.00156	CcSEcCtD
Bupivacaine—Hypersensitivity—Hydroxyurea—brain cancer	0.000408	0.00155	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000408	0.00155	CcSEcCtD
Bupivacaine—Muscle spasms—Etoposide—brain cancer	0.000408	0.00155	CcSEcCtD
Bupivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000407	0.00728	CbGpPWpGaD
Bupivacaine—Insomnia—Carmustine—brain cancer	0.000405	0.00154	CcSEcCtD
Bupivacaine—Paraesthesia—Carmustine—brain cancer	0.000402	0.00153	CcSEcCtD
Bupivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000402	0.00718	CbGpPWpGaD
Bupivacaine—Dyspnoea—Carmustine—brain cancer	0.000399	0.00151	CcSEcCtD
Bupivacaine—Somnolence—Carmustine—brain cancer	0.000398	0.00151	CcSEcCtD
Bupivacaine—Asthenia—Hydroxyurea—brain cancer	0.000398	0.00151	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000395	0.0015	CcSEcCtD
Bupivacaine—Anaemia—Etoposide—brain cancer	0.000392	0.00149	CcSEcCtD
Bupivacaine—PTGER1—Signaling by GPCR—OR14C36—brain cancer	0.000392	0.007	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—OR4C12—brain cancer	0.000392	0.007	CbGpPWpGaD
Bupivacaine—Insomnia—Temozolomide—brain cancer	0.000392	0.00148	CcSEcCtD
Bupivacaine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00039	0.00697	CbGpPWpGaD
Bupivacaine—Decreased appetite—Carmustine—brain cancer	0.00039	0.00148	CcSEcCtD
Bupivacaine—Paraesthesia—Temozolomide—brain cancer	0.000389	0.00147	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Carmustine—brain cancer	0.000387	0.00147	CcSEcCtD
Bupivacaine—Dyspnoea—Temozolomide—brain cancer	0.000386	0.00146	CcSEcCtD
Bupivacaine—Somnolence—Temozolomide—brain cancer	0.000385	0.00146	CcSEcCtD
Bupivacaine—Pain—Carmustine—brain cancer	0.000383	0.00145	CcSEcCtD
Bupivacaine—Constipation—Carmustine—brain cancer	0.000383	0.00145	CcSEcCtD
Bupivacaine—Dyspepsia—Temozolomide—brain cancer	0.000381	0.00144	CcSEcCtD
Bupivacaine—SCN10A—pituitary gland—brain cancer	0.000379	0.0467	CbGeAlD
Bupivacaine—Diarrhoea—Hydroxyurea—brain cancer	0.000379	0.00144	CcSEcCtD
Bupivacaine—Decreased appetite—Temozolomide—brain cancer	0.000376	0.00143	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000374	0.00142	CcSEcCtD
Bupivacaine—Loss of consciousness—Etoposide—brain cancer	0.000373	0.00141	CcSEcCtD
Bupivacaine—Cough—Etoposide—brain cancer	0.00037	0.0014	CcSEcCtD
Bupivacaine—Pain—Temozolomide—brain cancer	0.00037	0.0014	CcSEcCtD
Bupivacaine—Constipation—Temozolomide—brain cancer	0.00037	0.0014	CcSEcCtD
Bupivacaine—Feeling abnormal—Carmustine—brain cancer	0.000369	0.0014	CcSEcCtD
Bupivacaine—Convulsion—Etoposide—brain cancer	0.000368	0.00139	CcSEcCtD
Bupivacaine—Hypertension—Etoposide—brain cancer	0.000367	0.00139	CcSEcCtD
Bupivacaine—Dizziness—Hydroxyurea—brain cancer	0.000367	0.00139	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Carmustine—brain cancer	0.000366	0.00139	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000359	0.00136	CcSEcCtD
Bupivacaine—Feeling abnormal—Temozolomide—brain cancer	0.000357	0.00135	CcSEcCtD
Bupivacaine—Abdominal pain—Carmustine—brain cancer	0.000354	0.00134	CcSEcCtD
Bupivacaine—Body temperature increased—Carmustine—brain cancer	0.000354	0.00134	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Temozolomide—brain cancer	0.000354	0.00134	CcSEcCtD
Bupivacaine—Vomiting—Hydroxyurea—brain cancer	0.000352	0.00134	CcSEcCtD
Bupivacaine—Confusional state—Etoposide—brain cancer	0.000349	0.00132	CcSEcCtD
Bupivacaine—Headache—Hydroxyurea—brain cancer	0.000347	0.00132	CcSEcCtD
Bupivacaine—Anaphylactic shock—Etoposide—brain cancer	0.000346	0.00131	CcSEcCtD
Bupivacaine—Infection—Etoposide—brain cancer	0.000344	0.0013	CcSEcCtD
Bupivacaine—Urticaria—Temozolomide—brain cancer	0.000344	0.0013	CcSEcCtD
Bupivacaine—Body temperature increased—Temozolomide—brain cancer	0.000342	0.0013	CcSEcCtD
Bupivacaine—Abdominal pain—Temozolomide—brain cancer	0.000342	0.0013	CcSEcCtD
Bupivacaine—SCN4A—head—brain cancer	0.00034	0.0418	CbGeAlD
Bupivacaine—Tachycardia—Etoposide—brain cancer	0.000338	0.00128	CcSEcCtD
Bupivacaine—Skin disorder—Etoposide—brain cancer	0.000337	0.00128	CcSEcCtD
Bupivacaine—Hyperhidrosis—Etoposide—brain cancer	0.000335	0.00127	CcSEcCtD
Bupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00033	0.0059	CbGpPWpGaD
Bupivacaine—Hypersensitivity—Carmustine—brain cancer	0.00033	0.00125	CcSEcCtD
Bupivacaine—SCN4A—Axon guidance—TRPC6—brain cancer	0.000329	0.00589	CbGpPWpGaD
Bupivacaine—Nausea—Hydroxyurea—brain cancer	0.000329	0.00125	CcSEcCtD
Bupivacaine—SCN10A—spinal cord—brain cancer	0.000327	0.0402	CbGeAlD
Bupivacaine—Hypotension—Etoposide—brain cancer	0.000324	0.00123	CcSEcCtD
Bupivacaine—Asthenia—Carmustine—brain cancer	0.000321	0.00122	CcSEcCtD
Bupivacaine—Hypersensitivity—Temozolomide—brain cancer	0.000319	0.00121	CcSEcCtD
Bupivacaine—SCN10A—Axon guidance—TRPC6—brain cancer	0.000318	0.00567	CbGpPWpGaD
Bupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000314	0.00562	CbGpPWpGaD
Bupivacaine—CYP2D6—hindbrain—brain cancer	0.000312	0.0384	CbGeAlD
Bupivacaine—Paraesthesia—Etoposide—brain cancer	0.000311	0.00118	CcSEcCtD
Bupivacaine—Asthenia—Temozolomide—brain cancer	0.000311	0.00118	CcSEcCtD
Bupivacaine—SCN4A—central nervous system—brain cancer	0.00031	0.0382	CbGeAlD
Bupivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00031	0.00554	CbGpPWpGaD
Bupivacaine—Dyspnoea—Etoposide—brain cancer	0.000309	0.00117	CcSEcCtD
Bupivacaine—Somnolence—Etoposide—brain cancer	0.000308	0.00117	CcSEcCtD
Bupivacaine—Diarrhoea—Carmustine—brain cancer	0.000307	0.00116	CcSEcCtD
Bupivacaine—Pruritus—Temozolomide—brain cancer	0.000306	0.00116	CcSEcCtD
Bupivacaine—Decreased appetite—Etoposide—brain cancer	0.000301	0.00114	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Etoposide—brain cancer	0.000299	0.00113	CcSEcCtD
Bupivacaine—Dizziness—Carmustine—brain cancer	0.000296	0.00112	CcSEcCtD
Bupivacaine—Pain—Etoposide—brain cancer	0.000296	0.00112	CcSEcCtD
Bupivacaine—Constipation—Etoposide—brain cancer	0.000296	0.00112	CcSEcCtD
Bupivacaine—Diarrhoea—Temozolomide—brain cancer	0.000296	0.00112	CcSEcCtD
Bupivacaine—SCN10A—endocrine gland—brain cancer	0.000294	0.0361	CbGeAlD
Bupivacaine—SCN10A—head—brain cancer	0.00029	0.0357	CbGeAlD
Bupivacaine—Dizziness—Temozolomide—brain cancer	0.000286	0.00109	CcSEcCtD
Bupivacaine—Feeling abnormal—Etoposide—brain cancer	0.000286	0.00108	CcSEcCtD
Bupivacaine—Vomiting—Carmustine—brain cancer	0.000285	0.00108	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Etoposide—brain cancer	0.000283	0.00107	CcSEcCtD
Bupivacaine—Headache—Carmustine—brain cancer	0.000281	0.00106	CcSEcCtD
Bupivacaine—Vomiting—Temozolomide—brain cancer	0.000275	0.00104	CcSEcCtD
Bupivacaine—Urticaria—Etoposide—brain cancer	0.000275	0.00104	CcSEcCtD
Bupivacaine—Abdominal pain—Etoposide—brain cancer	0.000274	0.00104	CcSEcCtD
Bupivacaine—Body temperature increased—Etoposide—brain cancer	0.000274	0.00104	CcSEcCtD
Bupivacaine—Headache—Temozolomide—brain cancer	0.000271	0.00103	CcSEcCtD
Bupivacaine—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000267	0.00477	CbGpPWpGaD
Bupivacaine—Nausea—Carmustine—brain cancer	0.000266	0.00101	CcSEcCtD
Bupivacaine—SCN10A—central nervous system—brain cancer	0.000265	0.0326	CbGeAlD
Bupivacaine—Nausea—Temozolomide—brain cancer	0.000257	0.000975	CcSEcCtD
Bupivacaine—Hypersensitivity—Etoposide—brain cancer	0.000255	0.000968	CcSEcCtD
Bupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000255	0.00455	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—SHH—brain cancer	0.000254	0.00453	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—PTCH2—brain cancer	0.000253	0.00451	CbGpPWpGaD
Bupivacaine—Asthenia—Etoposide—brain cancer	0.000249	0.000942	CcSEcCtD
Bupivacaine—SCN4A—brain—brain cancer	0.000246	0.0303	CbGeAlD
Bupivacaine—Pruritus—Etoposide—brain cancer	0.000245	0.000929	CcSEcCtD
Bupivacaine—PTGER1—GPCR ligand binding—SMO—brain cancer	0.00024	0.00429	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—PTCH1—brain cancer	0.00024	0.00429	CbGpPWpGaD
Bupivacaine—Diarrhoea—Etoposide—brain cancer	0.000237	0.000899	CcSEcCtD
Bupivacaine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000237	0.00423	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—TRPC6—brain cancer	0.000235	0.0042	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—OR4C12—brain cancer	0.000232	0.00414	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—OR14C36—brain cancer	0.000232	0.00414	CbGpPWpGaD
Bupivacaine—Dizziness—Etoposide—brain cancer	0.000229	0.000869	CcSEcCtD
Bupivacaine—SCN10A—Developmental Biology—TRPC6—brain cancer	0.000227	0.00405	CbGpPWpGaD
Bupivacaine—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000225	0.00402	CbGpPWpGaD
Bupivacaine—SCN4A—L1CAM interactions—EGFR—brain cancer	0.000223	0.00399	CbGpPWpGaD
Bupivacaine—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000222	0.00397	CbGpPWpGaD
Bupivacaine—Vomiting—Etoposide—brain cancer	0.00022	0.000835	CcSEcCtD
Bupivacaine—PTGER1—GPCR downstream signaling—ABR—brain cancer	0.000218	0.0039	CbGpPWpGaD
Bupivacaine—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000217	0.00388	CbGpPWpGaD
Bupivacaine—Headache—Etoposide—brain cancer	0.000217	0.000823	CcSEcCtD
Bupivacaine—SCN10A—L1CAM interactions—EGFR—brain cancer	0.000215	0.00384	CbGpPWpGaD
Bupivacaine—SCN10A—brain—brain cancer	0.00021	0.0259	CbGeAlD
Bupivacaine—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.000207	0.0037	CbGpPWpGaD
Bupivacaine—Nausea—Etoposide—brain cancer	0.000206	0.00078	CcSEcCtD
Bupivacaine—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000204	0.00365	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—ABR—brain cancer	0.000198	0.00354	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—DTX2—brain cancer	0.000197	0.00352	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000181	0.00323	CbGpPWpGaD
Bupivacaine—CYP2D6—brainstem—brain cancer	0.000179	0.022	CbGeAlD
Bupivacaine—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000175	0.00313	CbGpPWpGaD
Bupivacaine—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000173	0.00309	CbGpPWpGaD
Bupivacaine—CYP2C19—endocrine gland—brain cancer	0.000172	0.0212	CbGeAlD
Bupivacaine—CYP2D6—telencephalon—brain cancer	0.000159	0.0195	CbGeAlD
Bupivacaine—SCN4A—Developmental Biology—HES1—brain cancer	0.000151	0.00271	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PTCH2—brain cancer	0.000149	0.00267	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—HES1—brain cancer	0.000146	0.00261	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—HES5—brain cancer	0.000144	0.00258	CbGpPWpGaD
Bupivacaine—CYP1A2—endocrine gland—brain cancer	0.000141	0.0173	CbGeAlD
Bupivacaine—PTGER1—Signaling Pathways—STRADA—brain cancer	0.00014	0.00251	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—TRPC6—brain cancer	0.000138	0.00247	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000135	0.00242	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000134	0.00239	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—SHH—brain cancer	0.00013	0.00232	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—TRPC6—brain cancer	0.000125	0.00224	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—SMO—brain cancer	0.000123	0.0022	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—PTCH1—brain cancer	0.000123	0.0022	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—ERBB2—brain cancer	0.000122	0.00217	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—CDK4—brain cancer	0.000119	0.00212	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—ERBB2—brain cancer	0.000117	0.0021	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—ABR—brain cancer	0.000117	0.00209	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—CDK4—brain cancer	0.000115	0.00205	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—GLI2—brain cancer	0.000113	0.00202	CbGpPWpGaD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.000111	0.00198	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—GLI1—brain cancer	0.000106	0.0019	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000104	0.00187	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—VAV1—brain cancer	0.000104	0.00185	CbGpPWpGaD
Bupivacaine—CYP3A4—endocrine gland—brain cancer	0.000102	0.0125	CbGeAlD
Bupivacaine—PTGER1—Signaling Pathways—SUFU—brain cancer	0.000101	0.0018	CbGpPWpGaD
Bupivacaine—CYP2D6—endocrine gland—brain cancer	0.0001	0.0123	CbGeAlD
Bupivacaine—CYP2D6—head—brain cancer	9.89e-05	0.0122	CbGeAlD
Bupivacaine—PTGER1—Signaling Pathways—GFAP—brain cancer	9.72e-05	0.00174	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	9.4e-05	0.00168	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—VAV1—brain cancer	9.4e-05	0.00168	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—VEGFA—brain cancer	9.37e-05	0.00167	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—HEY1—brain cancer	9.22e-05	0.00165	CbGpPWpGaD
Bupivacaine—CYP3A4—central nervous system—brain cancer	9.17e-05	0.0113	CbGeAlD
Bupivacaine—PTGER1—Signaling Pathways—DLL1—brain cancer	9.04e-05	0.00161	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—VEGFA—brain cancer	9.04e-05	0.00161	CbGpPWpGaD
Bupivacaine—CYP2D6—central nervous system—brain cancer	9.03e-05	0.0111	CbGeAlD
Bupivacaine—CYP2D6—cerebellum—brain cancer	8.82e-05	0.0109	CbGeAlD
Bupivacaine—SCN4A—Developmental Biology—RELA—brain cancer	8.74e-05	0.00156	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—ERBB2—brain cancer	8.68e-05	0.00155	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	8.65e-05	0.00154	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—EGFR—brain cancer	8.43e-05	0.00151	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—RELA—brain cancer	8.43e-05	0.00151	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—ERBB2—brain cancer	8.37e-05	0.0015	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—EGFR—brain cancer	8.13e-05	0.00145	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	7.99e-05	0.00143	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SHH—brain cancer	7.69e-05	0.00137	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—CTNNB1—brain cancer	7.6e-05	0.00136	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TRPC6—brain cancer	7.41e-05	0.00132	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	7.35e-05	0.00131	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—CTNNB1—brain cancer	7.33e-05	0.00131	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PTCH1—brain cancer	7.29e-05	0.0013	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SMO—brain cancer	7.29e-05	0.0013	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	7.19e-05	0.00128	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	7.19e-05	0.00128	CbGpPWpGaD
Bupivacaine—CYP2D6—brain—brain cancer	7.17e-05	0.00881	CbGeAlD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.74e-05	0.0012	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—VEGFA—brain cancer	6.69e-05	0.00119	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—STAT3—brain cancer	6.62e-05	0.00118	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—PIK3CG—brain cancer	6.57e-05	0.00117	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—VEGFA—brain cancer	6.45e-05	0.00115	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—STAT3—brain cancer	6.39e-05	0.00114	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.32e-05	0.00113	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—EGFR—brain cancer	6.02e-05	0.00108	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—PIK3CG—brain cancer	5.97e-05	0.00107	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NOTCH2—brain cancer	5.82e-05	0.00104	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—EGFR—brain cancer	5.8e-05	0.00104	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—VAV1—brain cancer	5.55e-05	0.000992	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.93e-05	0.00088	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—HES1—brain cancer	4.78e-05	0.000853	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—IL2—brain cancer	4.62e-05	0.000826	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PDGFRA—brain cancer	4.55e-05	0.000812	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SPP1—brain cancer	4.41e-05	0.000789	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—IL2—brain cancer	4.2e-05	0.00075	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IRS2—brain cancer	3.99e-05	0.000713	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP2C9—brain cancer	3.85e-05	0.000688	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP2C9—brain cancer	3.54e-05	0.000633	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—APC—brain cancer	3.53e-05	0.00063	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PIK3CG—brain cancer	3.53e-05	0.00063	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—BSG—brain cancer	3.27e-05	0.000585	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—EGFR—brain cancer	3.21e-05	0.000574	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—BSG—brain cancer	3.01e-05	0.000538	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP2C9—brain cancer	3e-05	0.000536	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—IDH1—brain cancer	2.82e-05	0.000503	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—RELA—brain cancer	2.75e-05	0.000492	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—ERBB2—brain cancer	2.74e-05	0.000489	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—IDH1—brain cancer	2.59e-05	0.000463	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—BSG—brain cancer	2.55e-05	0.000456	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IL2—brain cancer	2.48e-05	0.000443	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CCND1—brain cancer	2.42e-05	0.000432	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CTNNB1—brain cancer	2.4e-05	0.000428	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP2C9—brain cancer	2.32e-05	0.000414	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.29e-05	0.00041	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ENO2—brain cancer	2.23e-05	0.000398	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—IDH1—brain cancer	2.19e-05	0.000392	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—VEGFA—brain cancer	2.11e-05	0.000377	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—STAT3—brain cancer	2.09e-05	0.000373	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ENO2—brain cancer	2.05e-05	0.000366	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—BSG—brain cancer	1.97e-05	0.000352	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MYC—brain cancer	1.94e-05	0.000347	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—EGFR—brain cancer	1.9e-05	0.000339	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.79e-05	0.000319	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ENO2—brain cancer	1.73e-05	0.00031	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—IDH1—brain cancer	1.69e-05	0.000302	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TP53—brain cancer	1.59e-05	0.000285	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ENO2—brain cancer	1.34e-05	0.000239	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PIK3CG—brain cancer	1.02e-05	0.000182	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PIK3CG—brain cancer	9.39e-06	0.000168	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PIK3CG—brain cancer	7.95e-06	0.000142	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PIK3CG—brain cancer	6.14e-06	0.00011	CbGpPWpGaD
